Fermentation Optimization,isolation and Identification of Tirandamycins A and B from Marine-Derived Streptomyces Sp.scsio 1666

Duan Chuan-ren,Xinpeng Tian,Si Zhang,Changsheng Zhang,Jianhua Ju
2010-01-01
Abstract:Objective To screen antitumor and antibacterial agents from marine actinomycetes isolated from marine sediment,and strain Streptomyces sp.SCSI01666 was selected for further fermentation optimization to produce bioactive secondary metabolites.Methods Bioassay was conducted using in vitro antitumor activities against six tumor cell lines A549,DU145,H1299,HCT15,HEP3B,SF268,and using antibacterial models.The fermentation conditions of the strain were optimized and the bioactive secondary metabolites were isolated by means of solvent extraction,normal and reversed-phase silica gel.The structures of compounds were identified by physicochemical properties and spectral analyses. Results and Conclusion Two bioactive compounds were isolated guided by HPLC-UV and bioassay against Bacillus subtilis and their structures were identified as tirandamycin A(1) and tirandamycin B (2) from strain SCSI01666.The production of the two bioactive compounds was found to be marine salt dependent and there was only trace amount of compounds produced if no marine salt was added.The fermentation titer of the two compounds was improved more than 250-fold when 3%marine salt was added to the medium.Also,the fermentation titer of tirandamycin A was found to be greatly improved by addition of XAD-16 resin.
What problem does this paper attempt to address?